^ 2.02.12.22.32.42.5Learning about Neurofibromatosis. National Human Genome Research Institute (NHGRI). 16 August 2016 [7 November 2016]. (原始内容于10 October 2016). 该来源属于公有领域,本文含有该来源内容。
^Evans, Rosalie E. Ferner, Susan M. Huson, D. Gareth R. Neurofibromatoses in clinical practice. London: Springer. 2011: 1 [9 October 2015]. ISBN 978-0-85729-628-3. (原始内容于10 September 2017).
^Neurofibromatosis. NHS Choices. NHS. [9 October 2015]. (原始内容于25 September 2015).
^. NINDS. NIH. [9 October 2015]. (原始内容存档于2015-10-04).
^ 6.06.1. 23 February 2015 [2015-04-21]. (原始内容存档于2015-04-04).
^Choices, NHS. Neurofibromatosis type 1 - Causes - NHS Choices. www.nhs.uk. [2015-10-09]. (原始内容于24 September 2015).
^ 8.08.18.2Woodrow C, Clarke A, Amirfeyz R. Neurofibromatosis. Orthopaedics and Trauma. 1 June 2015, 29 (3): 206–210 [22 November 2019]. ISSN 1877-1327. doi:10.1016/j.mporth.2015.02.004. (原始内容于2021-08-28) (英语).
^Neurofibromatosis type 1. Genetics Home Reference. 5 October 2015 [2015-10-09]. (原始内容于10 September 2015).
^Neurofibromatosis type 2. Genetics Home Reference. 5 October 2015 [2015-10-09]. (原始内容于10 September 2015).
^Perry, Arie; Brat, Daniel J. Practical Surgical Neuropathology: A Diagnostic Approach. Elsevier Health Sciences. 1 January 2010: 435. ISBN 978-0443069826. (原始内容于2 May 2016).
^Orphanet: Neurofibromatosis type 1. www.orpha.net. [2015-10-13]. (原始内容于6 October 2015).
^Boyd, Kevin P.; Korf, Bruce R.; Theos, Amy. Neurofibromatosis type 1. Journal of the American Academy of Dermatology. 2009-07, 61 (1) [2022-10-08]. PMC 2716546. PMID 19539839. doi:10.1016/j.jaad.2008.12.051. (原始内容于2022-06-20) (英语). 引文格式1维护:PMC格式 (link)
^Conrad Fischer; Farshad Bagheri; Rajpal Manchandani; Richard Pinsker; Sudheer Chauhan; Parenkumar Patel; Mohammad Maruf; Dhaval Satani; Kaushik Doshi; Ayaz Alwani; Naveen Pathak; Craigh Thurm; Mohammad Babury; Mahendra C. Patel; Arthur Shalanov; Samir Sarkar; Sabiha Raouf; Jebun Nahar; Prakashkumar Patel. Master the Board USMLE Step 2 CK. KAPLAN Medical. 2010: 287. ISBN 978-1-60714-653-7.
^Neurofibromatosis. What is neurofibromatosis? Type 1 (NF1). Patient. [2015-10-09]. (原始内容于4 October 2015) (英国英语).
^Friedman, Jan M. Neurofibromatosis 1. Adam, Margaret P. (编). GeneReviews®. Seattle (WA): University of Washington, Seattle. 1993 [2022-10-08]. PMID 20301288. (原始内容于2022-10-25).
^Legius, Eric; Stevenson, David. Legius Syndrome. Adam, Margaret P. (编). GeneReviews®. Seattle (WA): University of Washington, Seattle. 1993 [2022-10-08]. PMID 20945555. (原始内容于2017-09-10).
^EL-Sobky, Tamer Ahmed; Elsayed, Solaf M.; EL Mikkawy, Dalia M. E. Orthopaedic manifestations of Proteus syndrome in a child with literature update. Bone Reports. 2015-12-01, 3 [2022-10-08]. ISSN 2352-1872. PMC 5365241. PMID 28377973. doi:10.1016/j.bonr.2015.09.004. (原始内容于2019-03-21) (英语). 引文格式1维护:PMC格式 (link)
^Choices, NHS. Neurofibromatosis type 2 - Treatment - NHS Choices. www.nhs.uk. [2015-10-11]. (原始内容于22 December 2015).
^Complex Neufibrmatosis type 1 (PDF). NHS.uk. NHS. [13 October 2015]. (原始内容 (PDF)于23 December 2015).
^Choices, NHS. Neurofibromatosis type 1 - Treatment - NHS Choices. www.nhs.uk. [2015-10-11]. (原始内容于26 September 2015).
^Norden, Andrew D.; Reardon, David A.; Wen, Patrick Y. Primary Central Nervous System Tumors: Pathogenesis and Therapy. Springer Science & Business Media. 16 December 2010: 459. ISBN 9781607611660. (原始内容于10 June 2016).
^Runge, Marschall S.; Patterson, Cam. Principles of Molecular Medicine. Springer Science & Business Media. 18 November 2007: 1160. ISBN 9781592599639. (原始内容于9 May 2016).
延伸閱讀编辑
Upadhyaya, Meena; Cooper, David. Neurofibromatosis Type 1: Molecular and Cellular Biology. Springer Science & Business Media. 29 January 2013 [2019-07-01]. ISBN 9783642328640. (原始内容于2016-04-23).
外部連結编辑
维基新闻中的相关報導:Interview with Reggie Bibbs on his life with neurofibromatosis